What Dicerna Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Pagan Douglas W. | Chief Financial Officer | Dec 28 | Tender Offer · U | −7,775 | $38.25 | −$297K | 0 |
| Smith Cynthia | Director | Dec 28 | Tender Offer · U | −3,333 | $38.25 | −$127K | 0 |
| Koppel Adam | Director | Dec 28 | Tender Offer · U | −3,080,237 | $38.25 | −$118M | 0 |
| Koppel Adam | Director | Dec 28 | Tender Offer · U | −3,333 | $38.25 | −$127K | 0 |
| Buchi J Kevin | Director | Dec 28 | Tender Offer · U | −4,666 | $38.25 | −$178K | 0 |
| Hoffman Stephen J | Director | Dec 28 | Tender Offer · U | −16,157 | $38.25 | −$618K | 0 |
| Kozin Marc D | Director | Dec 28 | Disposition to Issuer · D | −5,000 | $38.25 | −$191K | 0 |
| Kozin Marc D | Director | Dec 28 | Disposition to Issuer · D | −6,333 | $38.25 | −$242K | 0 |
| Doberstein Stephen K | Director | Dec 28 | Tender Offer · U | −3,333 | $38.25 | −$127K | 0 |
| Freed Martin I | Director | Dec 28 | Tender Offer · U | −3,333 | $38.25 | −$127K | 0 |
| Aradhye Shreeram | EVP & Chief Medical Officer | Dec 28 | Tender Offer · U | −6,973 | $38.25 | −$267K | 0 |
| Brown Bob | Chief Scientific Ofr., EVP R&D | Dec 28 | Tender Offer · U | −2,367 | $38.25 | −$90.5K | 0 |
| Ciappenelli Robert D. | Chief Strategy Officer | Dec 28 | Tender Offer · U | −14,813 | $38.25 | −$567K | 0 |
| Fambrough Douglas | Chief Executive Officer | Dec 28 | Disposition to Issuer · D | −231,431 | $38.25 | −$8.85M | 0 |
| Gray Patrick M. | Director | Dec 28 | Tender Offer · U | −3,333 | $38.25 | −$127K | 0 |
| Zeng Ling | Chief Legal Officer & Sec'y | Dec 28 | Tender Offer · U | −5,032 | $38.25 | −$192K | 0 |
| Weissman James B | Chief Operating Officer & EVP | Dec 28 | Tender Offer · U | −18,100 | $38.25 | −$692K | 0 |
| Pagan Douglas W. | Chief Financial Officer | Dec 15 | Withheld — tax / exercise cost · F | −602 | $38.05 | −$22.9K | 7,775 |
| Pagan Douglas W. | Chief Financial Officer | Dec 15 | Exercise / conversion · M | +2,050 | — | — | 8,377 |
| Weissman James B | Chief Operating Officer & EVP | Dec 15 | Withheld — tax / exercise cost · F | −1,675 | $38.05 | −$63.7K | 18,100 |
Loading...
